Join Now
06/16

Career Choice Series: Food, Drug, and Biotech Law



Format: Webinar

Worldwide Webinar

Dates: 06/16/2017

Time: 1 PM ET - 1:30 PM ET

Sponsor: ABA Legal Career Central
Young Lawyers Division
Law Student Division
and Section of Administrative Law and Regulatory Practice

List Price: FREE

ABA Member Price: FREE

Sponsor Member Price: FREE

REGISTER NOW

The Career Choice Series is designed to help you choose your career path. Whether you’re a law student, young lawyer, or transitioning attorney, find out what it’s like to work in various practice areas and the best way to position yourself to get there.

In this segment, our speakers will discuss their career paths working with clients who are regulated by the Food and Drug Administration (FDA), which can include food, drugs, cosmetics, and medical devices.

Professor James O’Reilly will discuss his career path which began as an Associate General Counsel at Procter & Gamble for 24 years where he worked to ensure the company’s products were FDA compliant and worked with Congress to create drug and medical device legislation. His book, Food and Drug Administration, West (1979-date, 3 vol. 5th Ed. 2015) was cited by the U.S. Supreme Court as “The expert” on FDA law. He also taught several courses at the University of Cincinnati College of Law including administrative law, food and drug law, and systems of regulation. He now teaches at the University of Cincinnati College of Medicine courses relating to public health services and sciences.

Edgar J. Asebey is an FDA attorney and partner at Keller Asebey Life Science Law. He has a background in molecular biology and early in his career worked as a patent and licensing specialist at the National Cancer Institute at NIH. Today he spends the majority of his time assisting clients with complex FDA compliance matters. He represents clients in all the life sciences (food, drug, cosmetics, and medical devices) – and has specialized in providing regulatory guidance to international client companies. Mr. Asebey also advises life science clients with regard to M&A, venture finance, IP licensing and transactional matters and has served as advisor to the governments of Japan and Colombia on FSMA compliance matters.

Speakers:
James T. O’Reilly, Professor of Public Health, University of Cincinnati College of Medicine, Cincinnati, OH
Edgar J. Asebey, Partner, Keller Asebey Life Science Law PLLC, Pompano Beach, FL

Moderator:
Liz Stone, Managing Director, The Dubin Group, San Francisco, CA

NOTE: This is not for CLE. The recording will be posted within 7 business days.

http://abaforlawstudents.com/feed/